Filter
1314
Filtered Results: 1314
Text search:
Foundation
for
Innovative
and
New
Diagnostics
Featured
Recommendations
109
New Publications
318
Language
Document type
No document type
708
Studies & Reports
265
Guidelines
136
Strategic & Response Plan
86
Manuals
75
Training Material
14
Fact sheets
14
Situation Updates
8
Resource Platforms
4
Online Courses
2
Brochures
1
Infographics
1
Countries / Regions
Global
82
India
47
Kenya
46
South Africa
26
Latin America and the Carribbean
25
Western and Central Europe
25
Ethiopia
24
Nigeria
23
Africa
23
Uganda
21
Malawi
20
Tanzania
20
Rwanda
17
Asia
17
Liberia
17
Myanmar / Burma
17
Ukraine
16
Ghana
16
Zambia
15
Nepal
13
Senegal
13
Eastern Europe
13
South–East Asia Region
12
Sierra Leone
11
Mozambique
11
East and Southern Africa
11
Bangladesh
11
Syria
8
Zimbabwe
8
Guinea
8
West and Central Africa
8
Philippines
7
Congo, Democratic Republic of
7
Namibia
7
Lesotho
6
Cambodia
6
Haiti
5
Middle East and North Africa
5
Botswana
5
South Sudan
5
Indonesia
5
Thailand
4
Burkina Faso
4
Afghanistan
4
Germany
4
Western Pacific Region
4
Brazil
4
Russia
4
Georgia
4
Pakistan
4
Colombia
3
China
3
Peru
3
Moldova
3
Sri Lanka
3
Cameroon
2
Laos
2
Estonia
2
Eastern Europe and Central Asia
2
Japan
2
United Kingdom
2
Belarus
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Yemen
2
Angola
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Benin
1
Chile
1
Iran
1
Albania
1
Malaysia
1
Qatar
1
Armenia
1
USA
1
Lithuania
1
Paraguay
1
Belgium
1
Mauritius
1
Spain
1
Southern Africa
1
Argentina
1
Papua New Guinea
1
Central African Republic
1
Mali
1
Chad
1
Bhutan
1
Iraq
1
Somalia
1
Ecuador
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
410
Clinical Guidelines
116
Public Health
108
Key Resources
44
Women & Child Health
41
Pharmacy & Technologies
33
Capacity Building
13
Toolboxes
HIV
159
TB
135
Mental Health
98
COVID-19
86
NTDs
57
AMR
47
Planetary Health
40
Caregiver
39
Health Financing Toolbox
38
Global Health Education
33
Disability
31
NCDs
27
Rapid Response
25
Ebola & Marburg
21
Pharmacy
20
Conflict
17
Polio
8
Refugee
7
Zika
5
Natural Hazards
4
Malaria
4
South Sudan
1
Cholera
1
Social Ethics
1
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
8 July 2020
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
This document provides a systematic approach in developing a coordinated, standardized, reliable, efficient, cost-effective, and sustainable specimen transport and referral system to support IVHD and VL testing networks. This document provides technical and programmatic recommendations on the approp...
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use as a crime that cannot be tolerated and should be punished; the other views addiction as a chronic re...
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr...
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
Second Edition
AIDS Medicines and diagnostics services
July 2015
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
